Disparities in clinical trial enrollment among patients with gastrointestinal cancer relative to minority-serving and safety-netting hospitals
Background For results to be generalizable to all patients with cancer, clinical trials need to
include a diverse patient demographic that is representative of the general population. We
sought to characterize the effect of receiving care at a minority-serving hospital (MSH) and/or
safety-net hospital on clinical trial enrollment among patients with gastrointestinal (GI)
malignancies. Methods Adult patients with GI cancer who underwent oncologic surgery and
were enrolled in institutional-/National Cancer Institute–funded clinical trials between 2012 …
include a diverse patient demographic that is representative of the general population. We
sought to characterize the effect of receiving care at a minority-serving hospital (MSH) and/or
safety-net hospital on clinical trial enrollment among patients with gastrointestinal (GI)
malignancies. Methods Adult patients with GI cancer who underwent oncologic surgery and
were enrolled in institutional-/National Cancer Institute–funded clinical trials between 2012 …
以上显示的是最相近的搜索结果。 查看全部搜索结果